A phase II trial proposal of total neoadjuvant treatment with primary chemotherapy, stereotactic body radiation therapy, and intraoperative radiation therapy in borderline resectable pancreatic adenocarcinoma.
Paiella S, Malleo G, Simoni N, Micera R, Guariglia S, Cavedon C, Marchegiani G, Esposito A, Landoni L, Casetti L, Tuveri M, Milella M, Secchettin E, Manzini G, Bovo C, De Pastena M, Fontana M, Salvia R, Mazzarotto R, Bassi C.
Paiella S, et al. Among authors: landoni l.
BMC Cancer. 2021 Feb 16;21(1):165. doi: 10.1186/s12885-021-07877-7.
BMC Cancer. 2021.
PMID: 33593311
Free PMC article.